Boston Scientific Corporation (BSX)
BSXNYSEMedical/Dental Instruments
$44.18
+0.1600 (+0.36%) today
Regular session, Nov 10, 2:09 PM ET
- Market cap
- $64.04bn
- P/E
- 13.8
- EPS, last 4 quarters
- $3.19
- Dividend yield
- –
- Day range
- $43.40 to $44.23
- 52-week range
- $39.57 to $105.65
- Average volume
- 8.68m
- Previous close
- $44.02
Analysts
22 coveringBuy14 buy, 8 hold, 0 sell
Targets a year out average $50.05, +13.3% from here
Earnings
next estimate $0.7800Next report
Dec 2025
+2.6%
Mar 2026
0.0%
Jun 2026
+3.6%
Sep 2026
0.0%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $5.29bn | $5.20bn | $5.44bn | $5.14bn |
| Gross profit | $3.68bn | $3.61bn | $3.85bn | $3.43bn |
| Operating income | $825.00m | $1.10bn | $1.18bn | $828.00m |
| Net income | $672.00m | $1.34bn | $907.00m | $582.00m |
Last four quarters: revenue $21.07bn, margin 16.6%, free cash flow $3.33bn
News
8 latest- Wall Street Analysts Look Bullish on Boston Scientific (BSX): Should You Buy?Zacks · 5 hours ago
- Here is What to Know Beyond Why Boston Scientific Corporation (BSX) is a Trending StockZacks · 5 days ago
- BSX Q3 Results Reset Growth Expectations as 2027 Outlook Stays WeakZacks · 6 days ago
- Is BSX Worth Buying Now as Low Valuation Meets Weak Earnings Growth?Zacks · Nov 3, 2026
- Boston Scientific Consensus Price Target Lowered by 10.06% to $57.12Fintel · Nov 2, 2026
- Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?Zacks · Oct 30, 2026
- JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4? Zacks · Oct 30, 2026
- New Strong Sell Stocks for October 30thZacks · Oct 30, 2026
The company
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NYSE
- Region
- North America
- Website
- bostonscientific.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.